Nomura Asset Management Co. Ltd. Acquires 4,356 Shares of Synopsys, Inc. $SNPS

Nomura Asset Management Co. Ltd. grew its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 7.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 66,604 shares of the semiconductor company’s stock after acquiring an additional 4,356 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Synopsys were worth $34,147,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of SNPS. Brighton Jones LLC lifted its position in Synopsys by 5.7% during the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after purchasing an additional 50 shares in the last quarter. Kingsview Wealth Management LLC raised its stake in shares of Synopsys by 28.2% in the first quarter. Kingsview Wealth Management LLC now owns 722 shares of the semiconductor company’s stock worth $310,000 after buying an additional 159 shares during the period. Kestra Private Wealth Services LLC lifted its position in shares of Synopsys by 7.7% during the 1st quarter. Kestra Private Wealth Services LLC now owns 5,229 shares of the semiconductor company’s stock valued at $2,242,000 after buying an additional 376 shares in the last quarter. Gallacher Capital Management LLC grew its stake in shares of Synopsys by 11.3% during the 1st quarter. Gallacher Capital Management LLC now owns 520 shares of the semiconductor company’s stock valued at $223,000 after acquiring an additional 53 shares during the period. Finally, Crestwood Advisors Group LLC purchased a new stake in Synopsys in the 1st quarter worth approximately $269,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insider Transactions at Synopsys

In related news, CFO Shelagh Glaser sold 3,655 shares of the stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the completion of the transaction, the chief financial officer directly owned 15,317 shares of the company’s stock, valued at approximately $9,339,847.09. This represents a 19.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the completion of the sale, the chief executive officer directly owned 71,615 shares in the company, valued at approximately $42,181,951.15. The trade was a 13.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 30,894 shares of company stock valued at $16,760,783 in the last ninety days. Corporate insiders own 0.62% of the company’s stock.

Wall Street Analysts Forecast Growth

SNPS has been the topic of several analyst reports. BNP Paribas initiated coverage on shares of Synopsys in a report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target on the stock. KeyCorp decreased their price objective on shares of Synopsys from $660.00 to $590.00 and set an “overweight” rating on the stock in a research report on Wednesday, September 10th. JPMorgan Chase & Co. lowered their target price on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 10th. Baird R W downgraded shares of Synopsys from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 10th. Finally, Stifel Nicolaus decreased their price target on Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Synopsys has a consensus rating of “Hold” and an average price target of $562.14.

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $383.82 on Wednesday. The firm has a market cap of $71.29 billion, a price-to-earnings ratio of 30.13, a P/E/G ratio of 5.02 and a beta of 1.10. The firm has a fifty day moving average price of $446.18 and a 200 day moving average price of $512.51. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The company had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same quarter in the previous year, the firm earned $3.43 EPS. The firm’s revenue for the quarter was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, sell-side analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.